ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
33 announcements
Fischer Medical Ventures reported audited FY26 results and recommended a Rs. 0.05 per share final dividend. The board also appointed S. Ramanand Aiyer & Co as internal auditors.
Fischer Medical Ventures scheduled a board meeting for May 29, 2026. Directors will consider FY26 audited financial results and potential dividend recommendations.
Fischer Medical subsidiary Time Medical India partnered with the WFNS Innovation Committee. This landmark collaboration focuses on advanced neurosurgical imaging and global medical technology training.